Percutaneous angioplasty and/or stenting versus aggressive medical therapy in patients with symptomatic intracranial atherosclerotic stenosis: a 1-year follow-up study
Open Access
- 16 June 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 15, 1192681
Abstract
Background: Symptomatic intracranial atherosclerotic stenosis (sICAS) is one of the common causes of ischemic stroke. However, the treatment of sICAS remains a challenge in the past with unfavorable findings. The purpose of this study was to explore the effect of stenting versus aggressive medical management on preventing recurrent stroke in patients with sICAS.Methods: We prospectively collected the clinical information of patients with sICAS who underwent percutaneous angioplasty and/or stenting (PTAS) or aggressive medical therapy from March 2020 to February 2022. Propensity score matching (PSM) was employed to ensure well-balanced characteristics of two groups. The primary outcome endpoint was defined as recurrent stroke or transient ischemic attack (TIA) within 1 year.Results: We enrolled 207 patients (51 in the PTAS and 156 in the aggressive medical groups) with sICAS. No significant difference was found between PTAS group and aggressive medical group for the risk of stroke or TIA in the same territory beyond 30 days through 6 months (P = 0.570) and beyond 30 days through 1 year (P = 0.739) except for within 30 days (P = 0.003). Furthermore, none showed a significant difference for disabling stroke, death and intracranial hemorrhage within 1 year. These results remain stable after adjustment. After PSM, all the outcomes have no significant difference between these two groups.Conclusion: The PTAS has similar treatment outcomes compared with aggressive medical therapy in patients with sICAS across 1-year follow-up.Keywords
This publication has 41 references indexed in Scilit:
- Effect of a Balloon-Expandable Intracranial Stent vs Medical Therapy on Risk of Stroke in Patients With Symptomatic Intracranial StenosisJAMA, 2015
- Outcomes of tailored angioplasty and/or stenting for symptomatic intracranial atherosclerosis: a prospective cohort study after SAMMPRISJournal of NeuroInterventional Surgery, 2014
- Intracranial atherosclerosisThe Lancet, 2014
- Prevalence and Outcomes of Symptomatic Intracranial Large Artery Stenoses and Occlusions in ChinaStroke, 2014
- Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trialThe Lancet, 2014
- High-Resolution Magnetic Resonance ImagingStroke, 2013
- Angioplasty and Stenting for Intracranial Atherosclerotic Stenosis With Nitinol StentOperative Neurosurgery, 2012
- Chronic cerebral hypoperfusion in a mouse model of Alzheimer's disease: An additional contributing factor of cognitive impairmentNeuroscience Letters, 2011
- Stroke in developing countries: can the epidemic be stopped and outcomes improved?The Lancet Neurology, 2007
- Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial StenosisCirculation, 2006